Haliborange

Quick links to important sections

Haliborange

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Haliborange

Quick Facts

Property Description
Active Ingredients Ascorbic Acid (Vitamin C), Calciferol (Vitamin D), Retinol (Vitamin A), Omega-3s
Form Liquid (Syrup), Chewable Tablets, Softies (Soft Gels)
Pharmacological Class Multivitamin and Mineral Supplementation
Common Use Nutritional Support and Maintenance of Everyday Health
Target Audience Primarily children (3–12 years)

What Type of Supplement is Haliborange?

Haliborange is an established Over-The-Counter (OTC) preparation classified pharmacologically as a Multivitamin and Mineral Supplementation product. It serves as a Nutritional Support Agent intended to provide essential micronutrients. This Combination Product delivers a broad blend of vitamins and minerals, fundamentally differing from prescriptive medicines by aiming to support general, everyday health. Its specialized market positioning focuses on palatable forms, such as fruit-flavored liquids and soft chews, reflecting its primary targeting of children and families for routine health maintenance.


Composition and Available Forms: Understanding the Ingredients

The core active ingredients are foundational vitamins, including Ascorbic Acid (Vitamin C), Calciferol (Vitamin D), and Retinol (Vitamin A), frequently enhanced with B-complex vitamins and Omega-3 Fatty Acids. Haliborange is designated as a semi-synthetic/derived oral product. While its heritage includes the use of Halibut Liver Oil, modern formulations often utilize alternative derived sources for the oil base, such as flaxseed oil. The preparation is consistently offered in various easy-to-consume dosage forms to suit its primary target audience, including the signature Liquid (Syrup), Chewable Tablets, and soft gel capsules known as Softies.


General Benefit: Why is Haliborange Used?

The general purpose of Haliborange is to contribute to fundamental physiological processes through consistent nutrient gap filling. This strategy of providing multiple key essential nutrients is intended for supporting the body’s baseline metabolic and structural needs. For instance, Vitamin D (Calciferol) is included to assist in regulating the absorption of calcium, which is essential for bone health. The combined ingredients also provide immune system support and contribute to the upkeep of essential bodily functions, such as normal vision and energy-yielding metabolism. The product is typically utilized as a measure to sustain nutrition, serving as a daily addition when dietary intake may be incomplete.

Regulatory References

  1. MedlinePlus Drug Information
  2. NIH Office of Dietary Supplements

What side effects are possible with Haliborange?

The safety profile for the components of this multivitamin supplement is defined by the toxicological risks associated with consuming amounts that exceed the established daily limits set by regulatory bodies, known as the Tolerable Upper Intake Level (UL).

Adverse Reaction Scope

The most frequent adverse reactions are generally mild and dose-dependent. These are classified primarily as Gastrointestinal Disorders, including nausea, vomiting, stomach discomfort, and loose stools. Additionally, Belching or the presence of a fishy taste is commonly documented with the Omega-3 component.

Serious Adverse Reactions documented in regulatory and toxicological literature are associated with chronic, excessive intake, leading to states of Hypervitaminosis A and D. These include severe, sustained Hypercalcemia (the defining endpoint of Vitamin D toxicity), severe headaches and increased intracranial pressure (Pseudotumor cerebri syndrome), and liver damage. The development of these severe effects is tied to prolonged ingestion, not short-term use.

Safety Considerations

Category Regulatory Notes
Population-Specific Excessive intake of preformed Vitamin A is noted as a risk for fetal harm (teratogenicity), mandating caution in pregnant individuals. Safety restrictions also apply to persons with pre-existing renal or hepatic disease due to impaired clearance of the components.
Key Restriction The consumption of the product's components must not surpass the established UL to mitigate the documented risk of Hypervitaminosis and associated severe conditions.

Connection to the Overall Safety Profile

The official safety information structures the product’s risk profile around the prevention of toxicity from overexposure, which is the most significant documented hazard. The classifications detail which organ systems (Gastrointestinal, Nervous, Renal) are affected when the established maximum safety limits are breached, ensuring awareness of the rare but serious risks tied to chronic, high-level use.

Overdose and Emergency Response

Overdose Manifestations and Required Actions

The official regulatory profile for this multivitamin preparation defines overdose risk primarily through the accumulated toxicities of its fat-soluble components, Vitamin A (Retinol) and Vitamin D (Calciferol). Overdose may result from chronic excessive intake or acute massive ingestion, leading to a range of severe consequences.

Documented Overdose Manifestations

Signs of overdose, as documented in regulatory sources, include a range of systemic effects. These may present as severe neurological symptoms such as headache, dizziness, and increased intracranial pressure (pseudotumor cerebri), particularly with Vitamin A excess. Gastrointestinal disturbances like nausea, vomiting, abdominal pain, and constipation are also noted.

Severe metabolic derangement, namely hypercalcemia from Vitamin D excess, can lead to frequent urination, bone pain, and in serious cases, cardiac arrhythmias or kidney failure (renal injury).

When to Seek Urgent Help

Regulatory guidance explicitly mandates to seek immediate medical attention for suspected overdose. In cases where the individual is experiencing severe signs such as collapse, a seizure, or difficulty breathing, official documentation requires calling emergency services immediately. Management involves immediate discontinuation and providing symptomatic and supportive treatment.

Population-specific considerations are documented, noting that children are at increased risk for growth problems, and excessive Vitamin A intake in pregnant individuals carries a documented risk of teratogenic effects.

Therapeutic Uses of Haliborange

Haliborange is used as a nutritional support agent to address common sub-optimal nutrient intake, primarily during the growth and development stages of children. It is commonly used to help address sub-optimal nutritional status that may lead to mild, chronic symptoms, rather than for the treatment of acute illness or severe deficiencies. Because supplemental Vitamins A, C, and D are often recommended for young children, this product may be part of symptomatic management for those needs.

The supplement is commonly used to help with symptom clusters related to lowered immune resilience, tiredness, which may be related to systemic imbalance, and the physiological stress of rapid growth. It is applied in clinical contexts that involve the maintenance of a normal skeletal and dental system, and supporting normal sensory and cognitive function.

“Consistent nutritional support contributes to improved day-to-day comfort and supports general well-being during routine activities.”

Haliborange is commonly used to help with normal immune system function, physical growth, and the maintenance of normal vision and cognitive health. This assists with the increased demands of development.


Quick Fact: Relief for Nutritional Gaps

Context of Use Primary Patient Benefit
Picky eating habits or restrictive diets Supports general well-being in situations where diet is limited.
Rapid childhood growth stages Contributes to the maintenance of bone and dental health.
Seasonal changes (e.g., low sunlight periods) Helps maintain a normal immune response and helps with symptoms related to systemic imbalance.

Regulatory References

  1. NHS guidance on vitamins for children

Eligibility and Restrictions for Use

The official eligibility profile for this nutritional supplement is structured around age requirements and mandatory regulatory warnings.

Age-Related Eligibility

  • Infants are eligible starting from 1 to 4 months of age for specialized Liquid or Drop formulations.
  • Children 3 years and over are approved for the Chewable Tablet and Softie forms.
  • Adults and Teenagers are eligible for use of "whole family" variants, with no specific geriatric restrictions noted in the public labeling.

Contraindications and Restrictions

  • Use is contraindicated in any individual with a known allergy or hypersensitivity to the active ingredients (Vitamins A, C, D, Omega-3s) or any other component listed in the product.
  • The supplement must not be used in children below the product's minimum age threshold (e.g., under 3 years old for solid forms).
  • Use is restricted and requires mandatory consultation with a doctor or pharmacist for patients with an underlying medical condition or those taking concurrent medications or other supplements.
  • Women who are pregnant, trying to conceive, or breastfeeding are instructed by the label to consult a healthcare professional before starting use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for the components of Haliborange (Vitamins A, C, D, and Omega-3s) focuses primarily on two patterns: alterations to drug exposure and pharmacodynamic reinforcement. Co-administration with other Vitamin A preparations is restricted due to the documented risk of additive toxicity, known as Hypervitaminosis A. The use of this product with other Vitamin D or Calcium supplements also carries a documented risk of inducing hypercalcaemia.

Pharmacodynamic reinforcement effects are noted with Anticoagulants, where the Omega-3 component may prolong bleeding time, and with certain Thiazide Diuretics, which increase the risk of hypercalcaemia when combined with Vitamin D.

Medicines documented to increase the metabolic clearance of Vitamin D, such as Phenytoin, Rifampicin, and Barbiturates, may reduce the efficacy of the supplement's Vitamin D component. Conversely, Ascorbic Acid (Vitamin C) is officially stated to increase the oral absorption of Iron preparations.

Mandatory Administration Timing

To prevent the impaired absorption of certain medicinal products caused by the calcium component, specific regulatory timing rules must be followed:

  • Levothyroxine administration must be separated by at least four hours.
  • Quinolone Antibiotics should be administered two hours before or six hours after ingestion.
  • Bisphosphonates and Sodium Fluoride must be taken at least three hours before the supplement.

Interaction-related cautions are also documented for specific populations, including the risk of hemolysis from Ascorbic Acid (Vitamin C) in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Mechanism of Action

How Haliborange Works: Mechanism of Action

The mechanism of Haliborange is defined by the coordinated actions of its essential micronutrient components, which function as vital cofactors and modulators within the body's existing biological machinery.


Genomic Regulation via Nuclear Receptor Activation

This domain covers the actions of Vitamin D and Vitamin A, whose active forms bind to nuclear receptors (VDR and RXR) inside cells. This binding creates a transcription factor that directly regulates the expression of genes crucial for calcium homeostasis, immune cell differentiation, and is required for the formation of Rhodopsin, which mediates visual phototransduction. The mechanism facilitates the proper absorption of calcium in the gut and regulates cell function through genetic programming.


Enzyme Cofactor Function and Structural Stability

The action of Vitamin C (Ascorbic Acid) centers on its function as a reducing agent essential for activating key enzymes, such as the Prolyl and Lysyl Hydroxylases. By maintaining the active state of these enzymes, the mechanism ensures the correct cross-linking and stabilization of the collagen triple helix. This physiological consequence is a requirement for the stability of all connective tissues, including bone matrix, skin, and blood vessel walls.


Cell Membrane Modulation and Inflammatory Shifting

The mechanism of Omega-3 Fatty Acids (EPA/DHA) involves their direct integration into cellular phospholipid bilayers. Once integrated, they modulate the activity of enzymes like COX and LOX by competing with pro-inflammatory substrates, which shifts the synthesis of eicosanoids towards less inflammatory mediators. This substrate-competition mechanism alters the profile of lipid mediators, changing the resulting systemic signaling.

Dosage and Administration Information

How to Use Haliborange

The usage of Haliborange is structured as an oral administration protocol with a consistent once-daily frequency across its various dosage forms. Dosing is primarily determined by the patient's age and the specific product formulation being used, requiring adherence to the recommended daily intake (RDI).


Official Administration Guidelines

Category Instruction or Principle
Route of administration The product is for oral administration in all forms, including Liquid, Chewable Tablets, and Softies.
Frequency pattern Administration is scheduled once daily for consistent nutritional support.
Labeled Dosing Regimen Dosing is tiered by age. For the specific Vitamin C 500 mg Effervescent Tablet (where licensed as a medicinal product), the regimen is one tablet daily for adults and children over 12 years.
Preparation Requirements Effervescent Tablets require mandatory preparation: the tablet must be fully dissolved in a minimum of 150 ml of water before ingestion.
Age-Group Rules Dosing is distinct for pediatric populations, with different measures required for infants (1–4 months) and toddlers (4 months–4 years) using the liquid formulation compared to older children and adults.
Procedural Constraint An explicit regulatory instruction for all Haliborange products is to not exceed the stated dose or the recommended daily intake.

Connection to the Overall Use Protocol

This protocol defines the standardized approach to using the product, which is fundamentally based on a once-daily oral schedule. The proper administration involves selecting the dose that corresponds to the specific age group and product form. For specific preparations, such as the Effervescent Tablets, the use protocol mandates a dissolution step in water prior to ingestion. This defined set of instructions regulates the method and timing of consumption, ensuring adherence to the labeled quantity.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Haliborange

This overview provides a neutral summary of the scientific research structure regarding the multivitamin and mineral components (such as Vitamins A, C, D, and Omega-3s) found in Haliborange, focusing only on the types of studies that exist and what was examined, without offering clinical recommendations or advice.


Evidence for Nutritional Support and Gap Filling

Research has explored the role of multivitamin and mineral supplements in individuals with sub-optimal nutrient status, a context that has been associated with restrictive diets or picky eating habits in children. The study designs often include short-term Randomized Controlled Trials (RCTs) and various observational cohort studies. Researchers primarily monitored levels of specific biomarkers in the blood, such as serum Vitamin D levels, to see how these levels change over time.

Findings from meta-analyses often describe patterns where a lower prevalence of deficiency for certain micronutrients was observed in supplemented groups compared to unsupplemented groups, particularly in populations where low baseline levels were already noted. However, the evidence regarding outcomes related to this type of supplementation in populations that are not clinically deficient appears to be more heterogeneous.

Evidence for Physical Growth Outcomes

Research examined the components' association with physical growth outcomes in supplementation trials. These studies were generally applied in research contexts involving children, where researchers examined outcomes such as anthropometric measures (like height and weight gain) and biochemical markers related to skeletal health.

In specific subgroups, such as children with confirmed baseline nutritional deficiencies, trials described patterns where measured values changed in growth-related assessments during the study period. However, research highlights that results were often inconsistent or the measured changes were small in magnitude when the study population comprised generally healthy children without documented deficits.

Evidence Gaps and Areas of Uncertainty

Research highlights that the evidence is limited in several key areas. The follow-up durations were limited in most studies, which means long-term effects are not fully established regarding the durability of changes in growth, nutritional status, or systemic function. Furthermore, comparative evidence is lacking to definitively separate the impact of the multi-ingredient blend versus the individual components, and subgroup findings for generally healthy populations remain uncertain.

Key Studies & References

  1. The therapeutic effects of multivitamins on growth in normal and malnourished children: A systematic review
  2. Where We Stand: Vitamin Supplements for Children - American Academy of Pediatrics

Frequently Asked Questions (FAQ)

Common questions about Haliborange (FAQ)


Q: Do regulatory agencies classify Haliborange as safe for general use?

A: Haliborange is legally marketed as an Over-The-Counter (OTC) product in regulated jurisdictions. This designation indicates that it has met the required quality and safety assurance standards when used exactly according to the official dosing instructions provided on the label. Official safety information focuses on the importance of adhering to the stated dose to avoid the risks associated with excessive intake.

Q: Is the Vitamin A content in Haliborange a common concern, and does it have specific warnings?

A: The official safety profile links specific risks to individual ingredients, requiring separate mandatory warnings on the label. Regulatory guidance highlights the potential risk of Vitamin A toxicity (Hypervitaminosis A) and its known risk for fetal harm. Official product information emphasizes caution for certain populations, such as women who are pregnant or trying to conceive.

Q: What is the difference between Haliborange softies and liquid?

A: The official product labeling indicates differences in physical form, active ingredients, and age suitability. For example, Softies are solid, chewable gels typically for children 3 years and older, while the liquid is a syrup form approved for use starting from infants as young as 1 month. The specific composition will be listed on each product’s label.

Q: Are the vitamins in Haliborange water-soluble or fat-soluble?

A: The product contains a combination of fat-soluble and water-soluble vitamins. The fat-soluble vitamins, such as A and D, are typically stored in the body. The water-soluble vitamins, such as C, are not stored and generally need to be obtained through regular intake.

Q: Is it possible to take Haliborange for too long a period?

A: Official safety documents state that using the product at the recommended daily dose has no defined time limitation. However, warnings are explicitly issued regarding chronic, excessive intake (overdosing for prolonged periods). This is associated with the rare risk of serious adverse effects like Hypervitaminosis.

Q: What is meant by 'RDA' in relation to the vitamins in Haliborange?

A: RDA (Recommended Dietary Allowance) is an official public health term used by authoritative regulatory bodies. It is defined as the average daily nutrient intake level estimated to be sufficient to meet the requirements of nearly all healthy people in a particular demographic. This term is related to the Recommended Daily Intake (RDI) found on product labels.

Q: Do studies exist that examine the benefits of Haliborange specifically?

A: The official evidence base is primarily comprised of studies that examine the effects and safety of the product's multivitamin and mineral components (like Vitamins A, C, D, and Omega-3s). These studies look at the general nutrient category rather than focusing on the branded product itself.

Q: Are the listed side effects of Haliborange common or rare?

A: Official safety information classifies the frequency of side effects. Mild reactions, such as gastrointestinal discomfort, belching, or a fishy taste, are classified as most frequent. Severe effects, which are linked to chronic overdose, are associated with rare occurrence.

Q: Does taking Haliborange prevent vitamin deficiency?

A: Haliborange is marketed as a nutritional support agent intended for nutrient gap filling. Research evidence describes patterns where a lower prevalence of deficiency for specific micronutrients was observed in supplemented groups when compared to unsupplemented groups.

Q: How should a parent interpret the 'recommended daily amount' on the Haliborange label?

A: The Recommended Daily Intake (RDI) is intended to be interpreted as the maximum quantity recommended for consumption in a day. The official administration guidelines emphasize that dosing is specifically tiered based on age and product form, and that the stated dose must not be exceeded.

Q: Does the time of day a person takes Haliborange matter?

A: Yes, the time of day matters significantly if the supplement is being taken concurrently with certain prescription medications. The official interactions section includes regulatory timing rules that mandate specific separation intervals (e.g., four hours) to prevent impaired absorption of those medicines.

Q: What evidence supports the claim that Haliborange contributes to normal bone health and energy-yielding metabolism?

A: The claimed benefits are supported by research examining the functions and biomarkers related to the supplement’s components. For example, studies describe the role of Vitamin D in calcium absorption for skeletal health, and the components contribute to normal energy-yielding metabolism.

Q: Why is 'fish' listed as a warning on some Haliborange packaging?

A: The 'fish' warning is included because certain formulations contain Omega-3 Fatty Acids, which may be derived from fish oil. Regulatory guidelines require the disclosure of common allergens on labels, and the product is contraindicated for those with known allergies to any component.

Q: What ingredients are used to give Haliborange its flavor, and are there differences between flavor variants?

A: The official product labeling requires the listing of all excipient ingredients, including flavorings, colorings, and sweeteners used in the formulation. Any difference between flavor variants, such as orange versus blackcurrant, will be reflected in a change to these listed ingredients. The complete list of these components can always be found on the product’s packaging.

Q: Is Haliborange free from artificial colors?

A: Official product labels must declare the use of all colorings. Some Haliborange products state they contain no artificial colors, relying instead on natural-source colorings like beta-carotene or carmines. Always check the ingredient list on the specific package for compliance information.

Q: Can Haliborange be taken on an empty stomach?

A: Haliborange contains certain fat-soluble vitamins (A and D) and Omega-3 fatty acids. General nutritional guidance suggests that these particular components are optimally absorbed when consumed alongside a meal that contains some fat.

Q: Is there a maximum age limit for using the Haliborange products designed for children?

A: The official product labeling for specific child-focused formulations, such as the Softies, clearly indicates the recommended upper age range for use. For instance, these products are commonly marketed as formulated and suitable for children aged up to 12 years.

Q: What if I miss a day of taking Haliborange?

A: Standard regulatory guidance for once-daily nutritional supplements suggests taking a missed dose when remembered. However, if it is almost time for the next scheduled dose, the individual may skip the missed dose and resume their regular schedule. Official instructions state not to take a double dose to compensate.

Q: Is Haliborange safe to take alongside common pain relievers?

A: Regulatory advisories suggest that combining any supplement with other medications, including common Over-The-Counter pain relievers, requires caution. The official interactions section lists specific timing rules for certain prescription drugs, but in all other cases, concurrent use requires professional consultation.

Q: Are there any specific food types that should be avoided when taking Haliborange?

A: General guidance for multivitamin supplements indicates that taking them within two hours of consuming large amounts of dairy products, antacids, or high-fiber foods may potentially impair the absorption of certain mineral components that can be present in multi-mineral supplements.

Q: Can Haliborange affect the results of certain medical tests?

A: High intake of certain vitamins, especially Vitamin C (Ascorbic Acid), can potentially interfere with the results of certain medical laboratory tests, such as those that measure glucose levels. Regulatory guidance advises that a healthcare professional should be informed that the supplement is being taken before any testing is performed.

Q: Does Haliborange have any known interactions with herbal supplements?

A: The full interaction profile with all herbal supplements is not fully established. Official product information states that any patient taking concurrent medications, including herbal or traditional supplements, is advised to seek consultation with a healthcare professional.

Q: What happens if an overdose of Haliborange is suspected?

A: Official safety guidance advises that emergency medical attention should be sought immediately if an overdose is suspected. Users are also advised to contact the poison control service in their region without delay.

Q: Is Haliborange required to follow GMP (Good Manufacturing Practice) guidelines?

A: As an Over-The-Counter supplement that is legally sold in regulated markets, Haliborange products are required to comply with Good Manufacturing Practice (GMP). This ensures they adhere to the necessary quality and safety assurance standards during manufacturing.

Q: What is the source of the gelatin or other gelling agents in Haliborange softies?

A: The official ingredient labeling for specific product forms, such as the Softie formulations, lists the gelling agent used. For certain variants, the label states that the Gelatine component is sourced from Bovine origin.

Q: Can a person stop taking Haliborange at any time?

A: Haliborange is classified as a nutritional supplement, not a prescription drug with risk of dependence or withdrawal effects. Due to this classification, the product labels do not typically include formal instructions or precautions about stopping use at any time.

How should Haliborange be stored and disposed of?

How to Store and Dispose of Haliborange?

The storage of Haliborange must strictly adhere to regulatory labeling to maintain product stability and potency.

Official Storage Requirements

Condition Requirement
Temperature Store below 25 C (for tablet forms).
Protection Keep the container tightly closed to protect from moisture, and store out of direct sunlight.
Post-Opening Stability Liquid forms must be refrigerated and used within 8 weeks of opening (for specific products) to maintain stability.
Child Safety Store the product out of the sight and reach of children.

Disposal

Unused or expired Haliborange product must be disposed of according to local regulations as mandated by official product labeling. This ensures the responsible handling of pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Haliborange found in:

A-Z Index: